Cargando…

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD

BACKGROUND: It is well known in Huntington's disease that cytosine‐adenine‐guanine expansion and age at study entry are predictive of the timing of motor diagnosis. The goal of this study was to assess whether additional motor, imaging, cognitive, functional, psychiatric, and demographic variab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Jeffrey D., Paulsen, Jane S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795466/ https://www.ncbi.nlm.nih.gov/pubmed/26340420 http://dx.doi.org/10.1002/mds.26364

Ejemplares similares

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
por: Paulsen, J S, et al.
Publicado: (2008)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
por: Paulsen, Jane S., et al.
Publicado: (2014)

Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE‐HD study
por: Turner, Lauren M., et al.
Publicado: (2016)

Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach
por: Ko, Jinnie, et al.
Publicado: (2023)

Disease Burden of Huntington’s Disease (HD) on People Living with HD and Care Partners in Canada
por: Shaw, Eileen, et al.
Publicado: (2022)

Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease
por: Kim, Ji-In, et al.
Publicado: (2015)

Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
por: Ouwerkerk, Jasper, et al.
Publicado: (2023)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study
por: Ahveninen, Lotta M., et al.
Publicado: (2018)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington’s Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits
por: Kudwa, Andrea E., et al.
Publicado: (2013)

Comprehensive shape analysis of the cortex in Huntington's disease
por: Stoebner, Zachary A., et al.
Publicado: (2022)

Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s disease
por: Long, Jeffrey D., et al.
Publicado: (2018)

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
por: Tucci, Paolo, et al.
Publicado: (2022)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker
por: Mason, Sarah L., et al.
Publicado: (2018)

Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease
por: Harrington, Deborah L, et al.
Publicado: (2014)

Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease
por: Holtbernd, Florian, et al.
Publicado: (2016)

Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
por: Seredenina, Tamara, et al.
Publicado: (2011)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE‐HD cohort
por: Alexander, Bonnie, et al.
Publicado: (2020)

Stem Cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington’s Disease
Publicado: (2021)

WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
por: Downing, Nancy R, et al.
Publicado: (2014)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington’s disease: the IMAGE-HD study
por: Tan, Brendan, et al.
Publicado: (2022)

A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study
por: Langbehn, Douglas R., et al.
Publicado: (2023)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Castro, Eduardo, et al.
Publicado: (2018)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
por: Sathe, Swati, et al.
Publicado: (2021)

Is a Motor Criterion Essential for the Diagnosis of Clinical Huntington Disease?
por: Loy, Clement T, et al.
Publicado: (2013)

Another Perspective on Huntington’s Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD
por: Achenbach, Jannis, et al.
Publicado: (2021)

Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease
por: Carlozzi, Noelle E., et al.
Publicado: (2014)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
por: Rocha, Natalia P., et al.
Publicado: (2018)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5b98p32or35rlj0ra84b1m799n